Answers are grounded in this paper and cite their sources.
This review discusses topical therapy options for upper respiratory tract conditions, highlighting efficacy and safety of treatments.
Anti-infectious immunity is a combination of mechanisms and responses that the body uses to resist external pathogens. The article describes the protective properties of one of these external barriers, the respiratory tract (RT) mucosa, as well as the factors affecting it and ways to correct the consequences of adverse effects. Methods for preventing or reducing the number of seasonal respiratory diseases and reducing the impact of adverse environmental factors are described, and data on the effect of topical drugs on the functional state of the RT epithelium and mucosa in the context of choosing the most "safe" drug without loss of clinical efficacy are presented. New data on the antiviral and anti-inflammatory activity of Euphorbium Compositum® Nasentropfen s nasal spray show that this topical agent helps to maintain the integrity of the epithelial barrier and improves the overall immunological and barrier functions of the RT ciliated epithelium and mucosa.
No takes yet. Share an insight, caveat, or question.
Радциг et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: